speb/financial-data huggingface dataset:
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1104000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1661000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1661000.00
CLEO.MC income_statement (annual, 2025-12-31) — Normalized EBITDA: 5519000.00
CLEO.MC income_statement (annual, 2025-12-31) — Normalized Income: 1987926.58
CLEO.MC cash_flow (annual, 2025-12-31) — Operating Cash Flow: 4454000.00
CLEO.MC income_statement (annual, 2025-12-31) — Operating Income: 1595000.00
CLEO.MC income_statement (annual, 2025-12-31) — Operating Revenue: 35695000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 14678849.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 14678849.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Other Current Assets: -2000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Other Current Assets: -2000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Other Current Liabilities: -2000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: -2000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Other Equity Interest: -21000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -21000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 3597000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 3597000.00
CLEO.MC cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1490000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 47000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 47000.00
CLEO.MC income_statement (annual, 2025-12-31) — Other Operating Expenses: 3205000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Other Payable: 7100000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Other Payable: 7100000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Other Properties: 1282000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Other Properties: 1282000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Other Receivables: 925000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Other Receivables: 925000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 1175000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 1175000.00
CLEO.MC income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Payables: 13719000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Payables: 13719000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1506000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1506000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Prepaid Assets: 37000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 37000.00
CLEO.MC income_statement (annual, 2025-12-31) — Pretax Income: 1975000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Properties: 41236000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Properties: 41236000.00
CLEO.MC cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -122000.00
CLEO.MC cash_flow (annual, 2025-12-31) — Purchase Of Investment: -630000.00
CLEO.MC cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2866000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Raw Materials: 220000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Raw Materials: 220000.00
CLEO.MC income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 12689000.00
CLEO.MC income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1641000.00
CLEO.MC income_statement (annual, 2025-12-31) — Rent And Landing Fees: 442000.00
CLEO.MC income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 442000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Retained Earnings: 1205000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1205000.00
CLEO.MC cash_flow (annual, 2025-12-31) — Sale Of PPE: 121000.00
CLEO.MC income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 14000.00
CLEO.MC income_statement (annual, 2025-12-31) — Selling General And Administration: 1046000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Share Issued: 14790416.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Share Issued: 14790416.00
CLEO.MC income_statement (annual, 2025-12-31) — Special Income Charges: -1241000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Stockholders Equity: 29934000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 29934000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Tangible Book Value: 26192000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 26192000.00
CLEO.MC income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -457073.42
CLEO.MC income_statement (annual, 2025-12-31) — Tax Provision: 728000.00
CLEO.MC income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.37
CLEO.MC balance_sheet (annual, 2025-12-31) — Taxes Receivable: 52000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 52000.00
CLEO.MC cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -114000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Total Assets: 91580000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Total Assets: 91580000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Total Capitalization: 32014000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 32014000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Total Debt: 35766000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Total Debt: 35766000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 30096000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 30096000.00
CLEO.MC income_statement (annual, 2025-12-31) — Total Expenses: 34100000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 61484000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 61484000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 71034000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 71034000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 43300000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 43300000.00
CLEO.MC income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1519000.00
CLEO.MC income_statement (annual, 2025-12-31) — Total Other Finance Cost: 803000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Total Tax Payable: 296000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 296000.00
CLEO.MC income_statement (annual, 2025-12-31) — Total Unusual Items: -1240000.00
CLEO.MC income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1240000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 7580000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 7580000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 111567.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 111567.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Treasury Stock: 746000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 746000.00
CLEO.MC balance_sheet (annual, 2025-12-31) — Working Capital: 2362000.00
CLEO.MC balance_sheet (quarterly, 2025-12-31) — Working Capital: 2362000.00
CLEO.MC income_statement (annual, 2025-12-31) — Write Off: 1227000.00
CLEX.BR income_statement (annual, 2021-12-31) — Basic Average Shares: 440000.00
CLEX.BR income_statement (annual, 2021-12-31) — Basic EPS: -0.15
CLEX.BR balance_sheet (annual, 2021-12-31) — Cash Financial: 8604.00
CLEX.BR income_statement (annual, 2021-12-31) — Diluted Average Shares: 440000.00
CLEX.BR income_statement (annual, 2021-12-31) — Diluted EPS: -0.15
CLEX.BR balance_sheet (annual, 2021-12-31) — Investments In Other Ventures Under Equity Method: 1.00
CLEX.BR balance_sheet (annual, 2021-12-31) — Preferred Shares Number: 110000.00
CLEX.BR income_statement (annual, 2022-12-31) — +Operating Expense: 91252.00
CLEX.BR income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Accounts Payable: 35533.00
CLEX.BR income_statement (annual, 2022-12-31) — Basic Average Shares: 440000.00
CLEX.BR income_statement (annual, 2022-12-31) — Basic EPS: -0.21
CLEX.BR balance_sheet (annual, 2022-12-31) — Capital Stock: 1835000.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 146.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 146.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Common Stock: 1835000.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Common Stock Equity: -2319115.00
CLEX.BR income_statement (annual, 2022-12-31) — Cost Of Revenue: 91252.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Current Assets: 146.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Current Debt: 0.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 0.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Current Liabilities: 2319263.00
CLEX.BR income_statement (annual, 2022-12-31) — Diluted Average Shares: 440000.00
CLEX.BR income_statement (annual, 2022-12-31) — Diluted EPS: -0.21
CLEX.BR income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -91252.00
CLEX.BR income_statement (annual, 2022-12-31) — EBIT: -182504.00
CLEX.BR income_statement (annual, 2022-12-31) — EBITDA: -182504.00
CLEX.BR income_statement (annual, 2022-12-31) — Gross Profit: -91252.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Invested Capital: -2319115.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 1.00
CLEX.BR income_statement (annual, 2022-12-31) — Net Income: -91252.00
CLEX.BR income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -91252.00
CLEX.BR income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -91252.00
CLEX.BR income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -91252.00
CLEX.BR income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -91252.00
CLEX.BR income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -91252.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -2319115.00
CLEX.BR income_statement (annual, 2022-12-31) — Normalized EBITDA: -182504.00
CLEX.BR income_statement (annual, 2022-12-31) — Normalized Income: -91252.00
CLEX.BR income_statement (annual, 2022-12-31) — Operating Income: -182504.00
CLEX.BR income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 440000.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2283730.00
CLEX.BR income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Payables: 35533.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 110000.00
CLEX.BR income_statement (annual, 2022-12-31) — Pretax Income: -91252.00
CLEX.BR income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 91252.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Retained Earnings: -4160145.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Share Issued: 440000.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Stockholders Equity: -2319115.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Tangible Book Value: -2319115.00
CLEX.BR income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLEX.BR income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Total Assets: 148.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Total Capitalization: -2319115.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Total Debt: 0.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -2319115.00
CLEX.BR income_statement (annual, 2022-12-31) — Total Expenses: 182504.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2319263.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 2.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CLEX.BR income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -91252.00
CLEX.BR balance_sheet (annual, 2022-12-31) — Working Capital: -2319117.00
CLEX.BR income_statement (annual, 2023-12-31) — +Operating Expense: 75906.00
CLEX.BR income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Accounts Payable: 29026.00
CLEX.BR income_statement (annual, 2023-12-31) — Basic Average Shares: 440000.00
CLEX.BR income_statement (annual, 2023-12-31) — Basic EPS: -0.17
CLEX.BR balance_sheet (annual, 2023-12-31) — Capital Stock: 1835000.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 209.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 209.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Common Stock: 1835000.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Common Stock Equity: -2395021.00
CLEX.BR income_statement (annual, 2023-12-31) — Cost Of Revenue: 75906.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Current Assets: 209.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Current Debt: 0.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 0.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Current Liabilities: 2395232.00
CLEX.BR income_statement (annual, 2023-12-31) — Diluted Average Shares: 440000.00
CLEX.BR income_statement (annual, 2023-12-31) — Diluted EPS: -0.17
CLEX.BR income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -75906.00
CLEX.BR income_statement (annual, 2023-12-31) — EBIT: -151812.00
CLEX.BR income_statement (annual, 2023-12-31) — EBITDA: -151812.00
CLEX.BR income_statement (annual, 2023-12-31) — Gross Profit: -75906.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Invested Capital: -2395021.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 1.00
CLEX.BR income_statement (annual, 2023-12-31) — Net Income: -75906.00
CLEX.BR income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -75906.00
CLEX.BR income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -75906.00
CLEX.BR income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -75906.00
CLEX.BR income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -75906.00
CLEX.BR income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -75906.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -2395021.00
CLEX.BR income_statement (annual, 2023-12-31) — Normalized EBITDA: -151812.00
CLEX.BR income_statement (annual, 2023-12-31) — Normalized Income: -75906.00
CLEX.BR income_statement (annual, 2023-12-31) — Operating Income: -151812.00
CLEX.BR income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 440000.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 2366206.00
CLEX.BR income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Payables: 29026.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 110000.00
CLEX.BR income_statement (annual, 2023-12-31) — Pretax Income: -75906.00
CLEX.BR income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 75906.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Retained Earnings: -4236051.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Share Issued: 440000.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Stockholders Equity: -2395021.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Tangible Book Value: -2395021.00
CLEX.BR income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLEX.BR income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Total Assets: 211.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Total Capitalization: -2395021.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Total Debt: 0.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -2395021.00
CLEX.BR income_statement (annual, 2023-12-31) — Total Expenses: 151812.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2395232.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CLEX.BR income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -75906.00
CLEX.BR balance_sheet (annual, 2023-12-31) — Working Capital: -2395023.00
CLEX.BR income_statement (annual, 2024-12-31) — +Operating Expense: 70558.00
CLEX.BR income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Accounts Payable: 30078.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 30078.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Capital Stock: 1835000.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Capital Stock: 1835000.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 3203.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 3203.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3203.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3203.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Common Stock: 1835000.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Common Stock: 1835000.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Common Stock Equity: -2465579.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -2465579.00
CLEX.BR income_statement (annual, 2024-12-31) — Cost Of Revenue: 70558.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Current Assets: 3203.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Current Assets: 3203.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Current Debt: 0.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Current Debt: 0.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 0.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 0.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Current Liabilities: 2468784.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 2468784.00
CLEX.BR income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -70558.00
CLEX.BR income_statement (annual, 2024-12-31) — EBIT: -141116.00
CLEX.BR income_statement (annual, 2024-12-31) — EBITDA: -141116.00
CLEX.BR income_statement (annual, 2024-12-31) — Gross Profit: -70558.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Invested Capital: -2465579.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Invested Capital: -2465579.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 1.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 1.00
CLEX.BR income_statement (annual, 2024-12-31) — Net Income: -70558.00
CLEX.BR income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -70558.00
CLEX.BR income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -70558.00
CLEX.BR income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -70558.00
CLEX.BR income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -70558.00
CLEX.BR income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -70558.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -2465579.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -2465579.00
CLEX.BR income_statement (annual, 2024-12-31) — Normalized EBITDA: -141116.00
CLEX.BR income_statement (annual, 2024-12-31) — Normalized Income: -70558.00
CLEX.BR income_statement (annual, 2024-12-31) — Operating Income: -141116.00
CLEX.BR income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 440000.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 440000.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2438706.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 2438706.00
CLEX.BR income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Payables: 30078.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Payables: 30078.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Preferred Shares Number: 110000.00
CLEX.BR income_statement (annual, 2024-12-31) — Pretax Income: -70558.00
CLEX.BR income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 70558.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Retained Earnings: -4306609.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -4306609.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Share Issued: 440000.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Share Issued: 440000.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Stockholders Equity: -2465579.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -2465579.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Tangible Book Value: -2465579.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -2465579.00
CLEX.BR income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CLEX.BR income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Total Assets: 3205.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Total Assets: 3205.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Total Capitalization: -2465579.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -2465579.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Total Debt: 0.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Total Debt: 0.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -2465579.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -2465579.00
CLEX.BR income_statement (annual, 2024-12-31) — Total Expenses: 141116.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2468784.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 2468784.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 2.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 2.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CLEX.BR income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -70558.00
CLEX.BR balance_sheet (annual, 2024-12-31) — Working Capital: -2465581.00
CLEX.BR balance_sheet (quarterly, 2024-12-31) — Working Capital: -2465581.00
CLEX.BR income_statement (annual, 2025-12-31) — +Operating Expense: 74797.00
CLEX.BR income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Accounts Payable: 24274.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 24274.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Capital Stock: 1835000.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1835000.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 102.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 102.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 102.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 102.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Common Stock: 1835000.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Common Stock: 1835000.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Common Stock Equity: -2540376.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -2540376.00
CLEX.BR income_statement (annual, 2025-12-31) — Cost Of Revenue: 74797.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Current Assets: 102.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Current Assets: 102.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Current Debt: 0.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Current Debt: 0.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 0.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 0.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Current Liabilities: 2540480.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2540480.00
CLEX.BR income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -74797.00
CLEX.BR income_statement (annual, 2025-12-31) — EBIT: -149594.00
CLEX.BR income_statement (annual, 2025-12-31) — EBITDA: -149594.00
CLEX.BR income_statement (annual, 2025-12-31) — Gross Profit: -74797.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Invested Capital: -2540376.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Invested Capital: -2540376.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 1.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1.00
CLEX.BR income_statement (annual, 2025-12-31) — Net Income: -74797.00
CLEX.BR income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -74797.00
CLEX.BR income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -74797.00
CLEX.BR income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -74797.00
CLEX.BR income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -74797.00
CLEX.BR income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -74797.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -2540376.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -2540376.00
CLEX.BR income_statement (annual, 2025-12-31) — Normalized EBITDA: -149594.00
CLEX.BR income_statement (annual, 2025-12-31) — Normalized Income: -74797.00
CLEX.BR income_statement (annual, 2025-12-31) — Operating Income: -149594.00
CLEX.BR income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 440000.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 440000.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 2516206.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 2516206.00
CLEX.BR income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Payables: 24274.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Payables: 24274.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 110000.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 110000.00
CLEX.BR income_statement (annual, 2025-12-31) — Pretax Income: -74797.00
CLEX.BR income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 74797.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Retained Earnings: -4381406.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -4381406.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Share Issued: 440000.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Share Issued: 440000.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Stockholders Equity: -2540376.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -2540376.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Tangible Book Value: -2540376.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -2540376.00
CLEX.BR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLEX.BR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Total Assets: 104.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Total Assets: 104.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Total Capitalization: -2540376.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -2540376.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Total Debt: 0.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Total Debt: 0.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -2540376.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -2540376.00
CLEX.BR income_statement (annual, 2025-12-31) — Total Expenses: 149594.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2540480.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2540480.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 2.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 2.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CLEX.BR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -74797.00
CLEX.BR balance_sheet (annual, 2025-12-31) — Working Capital: -2540378.00
CLEX.BR balance_sheet (quarterly, 2025-12-31) — Working Capital: -2540378.00
CLF balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -4000000.00
CLF balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 2158000000.00
CLF balance_sheet (annual, 2021-12-31) — Investments And Advances: 128000000.00
CLF balance_sheet (annual, 2021-12-31) — Investments In Other Ventures Under Equity Method: 128000000.00
CLF balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 128000000.00
CLF balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 8709000000.00
CLF cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: -1343000000.00
CLF cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 73000000.00
CLF income_statement (annual, 2021-12-31) — Other Operating Expenses: 80000000.00
CLF income_statement (annual, 2021-12-31) — Other Special Charges: 88000000.00
CLF balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 0.00
CLF cash_flow (annual, 2021-12-31) — Preferred Stock Payments: -1343000000.00
CLF cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 5962000000.00
CLF cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -5889000000.00
CLF balance_sheet (annual, 2021-12-31) — Total Tax Payable: 138000000.00
CLF income_statement (annual, 2022-12-31) — +Operating Expense: 546000000.00
CLF income_statement (annual, 2022-12-31) — +Total Revenue: 22989000000.00
CLF balance_sheet (annual, 2022-12-31) — Accounts Payable: 2186000000.00
CLF balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1960000000.00
CLF balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3318000000.00
CLF balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 4871000000.00
CLF balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -4000000.00
CLF cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 29000000.00
CLF income_statement (annual, 2022-12-31) — Basic Average Shares: 519455253.00
CLF income_statement (annual, 2022-12-31) — Basic EPS: 2.57
CLF cash_flow (annual, 2022-12-31) — Beginning Cash Position: 48000000.00
CLF balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 921000000.00
CLF cash_flow (annual, 2022-12-31) — Capital Expenditure: -943000000.00
CLF balance_sheet (annual, 2022-12-31) — Capital Stock: 66000000.00
CLF balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 26000000.00
CLF balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 26000000.00
CLF cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -1509000000.00
CLF cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -936000000.00
CLF cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 2423000000.00
CLF cash_flow (annual, 2022-12-31) — Change In Account Payable: -70000000.00
CLF cash_flow (annual, 2022-12-31) — Change In Inventory: 64000000.00
CLF cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -158000000.00
CLF cash_flow (annual, 2022-12-31) — Change In Payable: -70000000.00
CLF cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -70000000.00
CLF cash_flow (annual, 2022-12-31) — Change In Receivables: 197000000.00
CLF cash_flow (annual, 2022-12-31) — Change In Working Capital: 33000000.00
CLF cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 197000000.00
CLF cash_flow (annual, 2022-12-31) — Changes In Cash: -22000000.00
CLF balance_sheet (annual, 2022-12-31) — Common Stock: 66000000.00
CLF balance_sheet (annual, 2022-12-31) — Common Stock Equity: 7791000000.00
CLF cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CLF cash_flow (annual, 2022-12-31) — Common Stock Payments: -240000000.00
CLF balance_sheet (annual, 2022-12-31) — Construction In Progress: 552000000.00
CLF income_statement (annual, 2022-12-31) — Cost Of Revenue: 20471000000.00
CLF balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 812000000.00
CLF balance_sheet (annual, 2022-12-31) — Current Assets: 7422000000.00
CLF balance_sheet (annual, 2022-12-31) — Current Liabilities: 3549000000.00
CLF cash_flow (annual, 2022-12-31) — Deferred Income Tax: 90000000.00
CLF cash_flow (annual, 2022-12-31) — Deferred Tax: 90000000.00
CLF balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 356000000.00
CLF cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1034000000.00
CLF income_statement (annual, 2022-12-31) — Diluted Average Shares: 523529412.00
CLF income_statement (annual, 2022-12-31) — Diluted EPS: 2.55
CLF income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1335000000.00
CLF income_statement (annual, 2022-12-31) — EBIT: 2072000000.00
CLF income_statement (annual, 2022-12-31) — EBITDA: 3106000000.00
CLF cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
CLF balance_sheet (annual, 2022-12-31) — Employee Benefits: 1058000000.00
CLF cash_flow (annual, 2022-12-31) — End Cash Position: 26000000.00
CLF cash_flow (annual, 2022-12-31) — Financing Cash Flow: -1509000000.00
CLF balance_sheet (annual, 2022-12-31) — Finished Goods: 2971000000.00
CLF balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -1000000.00
CLF cash_flow (annual, 2022-12-31) — Free Cash Flow: 1480000000.00
CLF balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1830000000.00
CLF balance_sheet (annual, 2022-12-31) — Goodwill: 1130000000.00
CLF balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1344000000.00
CLF balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 1964000000.00
CLF balance_sheet (annual, 2022-12-31) — Gross PPE: 12388000000.00
CLF income_statement (annual, 2022-12-31) — Gross Profit: 2518000000.00
CLF income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CLF income_statement (annual, 2022-12-31) — Interest Expense: 276000000.00
CLF income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 276000000.00
CLF balance_sheet (annual, 2022-12-31) — Inventory: 5130000000.00
CLF balance_sheet (annual, 2022-12-31) — Invested Capital: 12040000000.00
CLF cash_flow (annual, 2022-12-31) — Investing Cash Flow: -936000000.00
CLF balance_sheet (annual, 2022-12-31) — Investments And Advances: 133000000.00
CLF balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 133000000.00
CLF cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CLF cash_flow (annual, 2022-12-31) — Issuance Of Debt: 255000000.00
CLF balance_sheet (annual, 2022-12-31) — Land And Improvements: 1388000000.00
CLF balance_sheet (annual, 2022-12-31) — Long Term Debt: 4249000000.00
CLF balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 4249000000.00
CLF cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 255000000.00
CLF cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1358000000.00
CLF balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 133000000.00
CLF balance_sheet (annual, 2022-12-31) — Minimum Pension Liabilities: 1847000000.00
CLF balance_sheet (annual, 2022-12-31) — Minority Interest: 251000000.00
CLF income_statement (annual, 2022-12-31) — Minority Interests: -41000000.00
CLF cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -31000000.00
CLF cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -240000000.00
CLF balance_sheet (annual, 2022-12-31) — Net Debt: 4223000000.00
CLF income_statement (annual, 2022-12-31) — Net Income: 1335000000.00
CLF income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1335000000.00
CLF income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1373000000.00
CLF income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 3000000.00
CLF income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1335000000.00
CLF income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1332000000.00
CLF cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1376000000.00
CLF income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1376000000.00
CLF income_statement (annual, 2022-12-31) — Net Interest Income: -276000000.00
CLF cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -1103000000.00
CLF cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1103000000.00
CLF income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -276000000.00
CLF cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -166000000.00
CLF cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 38000000.00
CLF balance_sheet (annual, 2022-12-31) — Net PPE: 9070000000.00
CLF cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -943000000.00
CLF cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
CLF cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 255000000.00
CLF balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 6447000000.00
CLF balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 590000000.00
CLF balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 590000000.00
CLF balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1058000000.00
CLF income_statement (annual, 2022-12-31) — Normalized EBITDA: 3214000000.00
CLF income_statement (annual, 2022-12-31) — Normalized Income: 1415160000.00
CLF cash_flow (annual, 2022-12-31) — Operating Cash Flow: 2423000000.00
CLF cash_flow (annual, 2022-12-31) — Operating Gains Losses: -132000000.00
CLF income_statement (annual, 2022-12-31) — Operating Income: 1972000000.00
CLF income_statement (annual, 2022-12-31) — Operating Revenue: 22383000000.00
CLF balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 513340779.00
CLF balance_sheet (annual, 2022-12-31) — Other Current Assets: 306000000.00
CLF balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 551000000.00
CLF balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -16000000.00
CLF income_statement (annual, 2022-12-31) — Other Income Expense: 100000000.00
CLF balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 214000000.00
CLF cash_flow (annual, 2022-12-31) — Other Non Cash Items: 22000000.00
CLF balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 430000000.00
CLF balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1267000000.00
CLF income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 208000000.00
CLF income_statement (annual, 2022-12-31) — Other Operating Expenses: 81000000.00
CLF balance_sheet (annual, 2022-12-31) — Other Properties: 9527000000.00
CLF income_statement (annual, 2022-12-31) — Other Special Charges: 75000000.00
CLF balance_sheet (annual, 2022-12-31) — Payables: 2186000000.00
CLF balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 2998000000.00
CLF cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: -132000000.00
CLF cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
CLF income_statement (annual, 2022-12-31) — Pretax Income: 1796000000.00
CLF cash_flow (annual, 2022-12-31) — Purchase Of Business: -31000000.00
CLF cash_flow (annual, 2022-12-31) — Purchase Of PPE: -943000000.00
CLF balance_sheet (annual, 2022-12-31) — Raw Materials: 2159000000.00
CLF balance_sheet (annual, 2022-12-31) — Receivables: 1960000000.00
CLF income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 20471000000.00
CLF income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1034000000.00
CLF cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1358000000.00
CLF cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -240000000.00
CLF income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 4000000.00
CLF balance_sheet (annual, 2022-12-31) — Retained Earnings: 1334000000.00
CLF cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CLF income_statement (annual, 2022-12-31) — Selling General And Administration: 465000000.00
CLF balance_sheet (annual, 2022-12-31) — Share Issued: 531051530.00
CLF cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 5749000000.00
CLF cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -5494000000.00
CLF income_statement (annual, 2022-12-31) — Special Income Charges: -108000000.00
CLF balance_sheet (annual, 2022-12-31) — Stockholders Equity: 7791000000.00
CLF balance_sheet (annual, 2022-12-31) — Tangible Book Value: 6447000000.00
CLF income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -24840000.00
CLF income_statement (annual, 2022-12-31) — Tax Provision: 423000000.00
CLF income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
CLF balance_sheet (annual, 2022-12-31) — Total Assets: 18755000000.00
CLF balance_sheet (annual, 2022-12-31) — Total Capitalization: 12040000000.00
CLF balance_sheet (annual, 2022-12-31) — Total Debt: 4249000000.00
CLF balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 8042000000.00
CLF income_statement (annual, 2022-12-31) — Total Expenses: 21017000000.00
CLF balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 10713000000.00
CLF balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 11333000000.00
CLF balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 7164000000.00
CLF income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 1939000000.00
CLF income_statement (annual, 2022-12-31) — Total Unusual Items: -108000000.00
CLF income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -108000000.00
CLF balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 17710751.00
CLF balance_sheet (annual, 2022-12-31) — Treasury Stock: 310000000.00
CLF balance_sheet (annual, 2022-12-31) — Working Capital: 3873000000.00
CLF income_statement (annual, 2022-12-31) — Write Off: 29000000.00
CLF income_statement (annual, 2023-12-31) — +Operating Expense: 577000000.00
CLF income_statement (annual, 2023-12-31) — +Total Revenue: 21996000000.00
CLF balance_sheet (annual, 2023-12-31) — Accounts Payable: 2099000000.00
CLF balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1840000000.00
CLF balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -4012000000.00
CLF balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 4861000000.00
CLF balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -5000000.00
CLF cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 125000000.00
CLF income_statement (annual, 2023-12-31) — Basic Average Shares: 511538462.00
CLF income_statement (annual, 2023-12-31) — Basic EPS: 0.78
CLF cash_flow (annual, 2023-12-31) — Beginning Cash Position: 26000000.00
CLF balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 946000000.00
CLF cash_flow (annual, 2023-12-31) — Capital Expenditure: -646000000.00
CLF balance_sheet (annual, 2023-12-31) — Capital Stock: 66000000.00
CLF balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 198000000.00
CLF balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 198000000.00
CLF cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -1504000000.00
CLF cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -591000000.00
CLF cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 2267000000.00
CLF cash_flow (annual, 2023-12-31) — Change In Account Payable: 22000000.00
CLF cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 122000000.00
CLF cash_flow (annual, 2023-12-31) — Change In Inventory: 670000000.00
CLF cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -130000000.00
CLF cash_flow (annual, 2023-12-31) — Change In Payable: 144000000.00
CLF cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 144000000.00
CLF cash_flow (annual, 2023-12-31) — Change In Receivables: 120000000.00
CLF cash_flow (annual, 2023-12-31) — Change In Tax Payable: 122000000.00
CLF cash_flow (annual, 2023-12-31) — Change In Working Capital: 804000000.00
CLF cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 120000000.00
CLF cash_flow (annual, 2023-12-31) — Changes In Cash: 172000000.00
CLF balance_sheet (annual, 2023-12-31) — Common Stock: 66000000.00
CLF balance_sheet (annual, 2023-12-31) — Common Stock Equity: 7887000000.00
CLF cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CLF cash_flow (annual, 2023-12-31) — Common Stock Payments: -152000000.00
CLF balance_sheet (annual, 2023-12-31) — Construction In Progress: 590000000.00
CLF income_statement (annual, 2023-12-31) — Cost Of Revenue: 20623000000.00
CLF balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 891000000.00
CLF balance_sheet (annual, 2023-12-31) — Current Assets: 6636000000.00
CLF balance_sheet (annual, 2023-12-31) — Current Liabilities: 3508000000.00
CLF cash_flow (annual, 2023-12-31) — Deferred Income Tax: 110000000.00
CLF cash_flow (annual, 2023-12-31) — Deferred Tax: 110000000.00
CLF balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 329000000.00
CLF cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 973000000.00
CLF income_statement (annual, 2023-12-31) — Diluted Average Shares: 511538462.00
CLF income_statement (annual, 2023-12-31) — Diluted EPS: 0.78
CLF income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 385000000.00
CLF income_statement (annual, 2023-12-31) — EBIT: 868000000.00
CLF income_statement (annual, 2023-12-31) — EBITDA: 1841000000.00
CLF cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
CLF balance_sheet (annual, 2023-12-31) — Employee Benefits: 821000000.00
CLF cash_flow (annual, 2023-12-31) — End Cash Position: 198000000.00
CLF cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1504000000.00
CLF balance_sheet (annual, 2023-12-31) — Finished Goods: 2573000000.00
CLF balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: 0.00
CLF cash_flow (annual, 2023-12-31) — Free Cash Flow: 1621000000.00